Novophage Garners $5,750,000 Series A Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    Undisclosed Cambridge, MA 02140
  • Company Description
    Novophage is developing a first-in-class anti-biofilm solution that is green and highly effective against biofilms.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company will use the money to continue development of its technology that battles biofilms in HVAC systems and paper production.
  • M&A Terms
  • Venture Investor
    Flybridge Capital Partners
  • Venture Investor
    Founder Collective
  • Venture Investor
    The Kraft Group

Trending on Xconomy